Dr. Connor is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3701 Market Street
7th Floor
Philadelphia, PA 19104Phone+1 215-349-5200
Education & Training
Pennsylvania Hospital of the University of Pennsylvania Health SystemResidency, Internal Medicine, 2018 - 2021
Chicago Medical School at Rosalind Franklin University of Medicine and ScienceClass of 2018
Certifications & Licensure
PA State Medical License 2018 - 2026- American Board of Internal Medicine Internal Medicine
Publications & Presentations
PubMed
- 2 citationsImpact of prior inotuzumab ozogamicin treatment on brexucabtagene autoleucel outcomes in adults with B-cell ALL.Ibrahim Aldoss, Gregory W Roloff, Rawan Faramand, Noam E Kopmar, Chenyu Lin
Blood Advances. 2024-12-10 - 2 citationsOutcomes After Brexucabtagene Autoleucel Administered as a Standard Therapy for Adults With Relapsed/Refractory B-Cell ALL.Gregory W Roloff, Ibrahim Aldoss, Noam E Kopmar, Chenyu Lin, Simone E Dekker
Journal of Clinical Oncology. 2024-10-17 - Hypomethylating agents are associated with high rates of hematologic toxicity in patients with secondary myeloid neoplasms developing after acquired aplastic anemia.Matthew P Connor, Neeharika Prathapa, Noelle V Frey, Saar I Gill, Elizabeth O Hexner
Haematologica. 2024-08-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
